Current Strategy for Medicating Patients May Be Giving Many Drug-Resistant Diseases a Big Competitive Advantage

Related content

• Scholarly Works

• The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy

  Research output: Contribution to journal › Article › peer-review